MedPath

Medical University of Vienna

Medical University of Vienna logo
🇦🇹Austria
Ownership
Private
Established
1365-01-01
Employees
1K
Market Cap
-
Website
http://www.meduniwien.ac.at

PDS Versus Prolene as Suture Material for Vaginal Sacrospinous Hysteropexy

Not Applicable
Recruiting
Conditions
Prolapse
Pelvic Organ Prolapse
Interventions
Procedure: sacrospinous hysteropexy
First Posted Date
2023-07-28
Last Posted Date
2023-09-05
Lead Sponsor
Medical University of Vienna
Target Recruit Count
52
Registration Number
NCT05964881
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.

Recruiting
Conditions
McArdle Disease
Pompe Disease
Interventions
Device: Siemens Magnetom 7T Plus
First Posted Date
2023-07-13
Last Posted Date
2023-10-23
Lead Sponsor
Medical University of Vienna
Target Recruit Count
30
Registration Number
NCT05943678
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Tele-reha Versus Paper-based Aftercare Programme Following Inpatient Rehabilitation

Not Applicable
Recruiting
Conditions
Neurologic Disorder
Interventions
Device: Tele-Reha provided with EvoPads
Other: Only paper-based exercises
Other: Paper-based exercises with option to do tele-reha afterwards
First Posted Date
2023-07-11
Last Posted Date
2024-12-09
Lead Sponsor
Medical University of Vienna
Target Recruit Count
285
Registration Number
NCT05940584
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Organ Interaction Patterns in Healthy Individuals for Improved PET/CT Diagnostics

Not Applicable
Not yet recruiting
Conditions
Healthy
Interventions
Device: Siemens Quadra PET/CT and [18F]FDG
Device: Apple i-Watch
First Posted Date
2023-07-07
Last Posted Date
2023-07-07
Lead Sponsor
Medical University of Vienna
Target Recruit Count
50
Registration Number
NCT05936411

Mechanism of Human Cold Pain Perception - Involvement of TRPA1, TRPM8, Nav1.7 and Nav1.8

Early Phase 1
Completed
Conditions
Pain
Interventions
Other: Room temperature
Other: Cold temperature
Drug: PF-06305591
Drug: Lidocain
Drug: A967079
Drug: PF-05105679
Drug: PF-05089771
First Posted Date
2023-07-07
Last Posted Date
2024-03-15
Lead Sponsor
Medical University of Vienna
Target Recruit Count
36
Registration Number
NCT05935280
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Vagus Stimulation in Female Long COVID Patients.

Not Applicable
Recruiting
Conditions
Post-COVID Syndrome
Post COVID-19 Condition
Post COVID Condition
Vagus Nerve Diseases
Long COVID
Post-COVID-19 Syndrome
Long Covid19
Interventions
Device: transcutaneous electrical vagal neurostimulation
First Posted Date
2023-06-26
Last Posted Date
2023-06-26
Lead Sponsor
Medical University of Vienna
Target Recruit Count
45
Registration Number
NCT05918965
Locations
🇦🇹

Department of Physical Medicine, Rehabilitation and Occupational Medicine, Medical University of Vienna, Vienna, Austria

Predicting Lung Cancer-Associated Cachexia With PET Imaging

Not Applicable
Recruiting
Conditions
Cachexia
Lung Neoplasm
Interventions
Other: Stress Reduction Training
First Posted Date
2023-06-22
Last Posted Date
2023-06-27
Lead Sponsor
Medical University of Vienna
Target Recruit Count
150
Registration Number
NCT05912465
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

🇮🇹

AOUC Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

🇩🇪

University of Leipzig Medical Center, Leipzig, Germany

Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis

Completed
Conditions
Aortic Valve Disease
Interventions
Device: Aortic Valve Replacement
First Posted Date
2023-06-22
Last Posted Date
2023-06-22
Lead Sponsor
Medical University of Vienna
Target Recruit Count
18882
Registration Number
NCT05912660

Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation

Not Applicable
Recruiting
Conditions
Congenital Heart Disease
Airway Complication of Anesthesia
Interventions
Device: laryngoscopy
First Posted Date
2023-06-13
Last Posted Date
2024-07-12
Lead Sponsor
Medical University of Vienna
Target Recruit Count
180
Registration Number
NCT05902013
Locations
🇦🇹

Medical University Vienna, Vienna, Austria

Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma

Phase 2
Recruiting
Conditions
Mantle-cell Lymphoma
Interventions
First Posted Date
2023-05-22
Last Posted Date
2024-05-29
Lead Sponsor
Medical University of Vienna
Target Recruit Count
16
Registration Number
NCT05868395
Locations
🇦🇹

AKH Vienna, Division of Oncology Department of Medicine I, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath